Tag: GxP compliance

Sustaining DI Improvements After Major Remediation: Monitoring and Governance Sustaining Data Integrity Improvements After Major Remediation: A Practical Guide to Monitoring and Governance Data integrity is a cornerstone of pharmaceutical manufacturing compliance, underpinning trust in product quality, patient safety, and regulatory adherence. Following a significant data integrity (DI) remediation effort, the challenge shifts from correction…

Read More “Sustaining DI Improvements After Major Remediation: Monitoring and Governance” »

DI Aspects of Real-Time Dashboards and BI Tools for Quality and Operations Data Integrity Aspects of Real-Time Dashboards and BI Tools for Quality and Operations In the pharmaceutical industry, maintaining data integrity is paramount to ensure compliance with regulatory requirements and uphold patient safety. Real-time dashboards and Business Intelligence (BI) tools have become invaluable assets…

Read More “DI Aspects of Real-Time Dashboards and BI Tools for Quality and Operations” »

Future Trends in DI Enforcement From FDA, EMA, MHRA and Other Agencies Future Trends in Data Integrity Enforcement: A Step-by-Step Guide for Pharma Professionals Data integrity remains a cornerstone of Good Manufacturing Practice (GMP) and Good Automated Manufacturing Practice (GAMP) compliance in pharmaceutical manufacturing and clinical operations. As regulatory authorities worldwide continue to strengthen their…

Read More “Future Trends in DI Enforcement From FDA, EMA, MHRA and Other Agencies” »

Aligning Data Integrity Controls With ICH Q9 and ICH Q10 Frameworks Practical Guide to Aligning Data Integrity Controls with ICH Q9 and ICH Q10 Frameworks Ensuring data integrity is a foundational requirement for pharmaceutical quality systems worldwide. The increasing complexity of digital manufacturing environments, combined with evolving regulatory expectations particularly under 21 CFR Part 11…

Read More “Aligning Data Integrity Controls With ICH Q9 and ICH Q10 Frameworks” »

Integrating DI Considerations Into Quality Risk Management Methodologies Step-by-Step Integration of Data Integrity Considerations Into Quality Risk Management Methodologies In the pharmaceutical industry, compliance with Good Manufacturing Practice (GMP) regulatory requirements is critical for ensuring patient safety and product quality. A key component of GMP compliance is maintaining data integrity—ensuring GxP records remain accurate, complete,…

Read More “Integrating DI Considerations Into Quality Risk Management Methodologies” »

Data Integrity Challenges in ATMP and Personalized Medicine Facilities Addressing Data Integrity Challenges in ATMP and Personalized Medicine Facilities Advanced Therapy Medicinal Products (ATMPs) and personalized medicine represent cutting-edge frontiers in pharmaceutical development and manufacture. However, these emerging modalities pose unique challenges to maintaining data integrity within Good Manufacturing Practice (GMP) environments. This step-by-step guide…

Read More “Data Integrity Challenges in ATMP and Personalized Medicine Facilities” »

Data Integrity Governance in Mergers, Acquisitions and Site Transfers Step-by-Step Guide to Data Integrity Governance in Mergers, Acquisitions and Site Transfers In pharmaceutical manufacturing and clinical operations, maintaining data integrity during organizational changes such as mergers, acquisitions, and site transfers is critical to ensuring compliance with regulatory frameworks including 21 CFR Part 11 and Annex…

Read More “Data Integrity Governance in Mergers, Acquisitions and Site Transfers” »

Using External DI Audits to Validate Internal Controls and Culture Leveraging External Data Integrity Audits to Strengthen Internal Controls and Organizational Culture Data integrity continues to be a cornerstone of pharmaceutical quality systems worldwide, underpinning reliable manufacturing, clinical trials, and regulatory compliance. Global regulators including the FDA, EMA, and MHRA have intensified scrutiny on data…

Read More “Using External DI Audits to Validate Internal Controls and Culture” »

Communicating DI Expectations to External Partners, CMOs and CROs Effective Communication of Data Integrity Expectations to External Partners, CMOs, and CROs Maintaining data integrity within pharmaceutical development and manufacturing is non-negotiable throughout the product lifecycle. The US FDA, EMA, MHRA, and other regulatory agencies hold pharmaceutical companies accountable for ensuring that all GxP records generated…

Read More “Communicating DI Expectations to External Partners, CMOs and CROs” »

Data Integrity in Document Scanning, OCR and Digital Archive Projects Ensuring Data Integrity in Document Scanning, OCR, and Digital Archive Projects: A Step-by-Step Guide Maintaining data integrity throughout pharmaceutical document management processes is essential for compliance with regulatory authorities such as the FDA, EMA, MHRA, and global GMP standards. In regulated pharma environments, scanning of…

Read More “Data Integrity in Document Scanning, OCR and Digital Archive Projects” »